+1 347 708 0418
The Next Generation Sequencing (NGS) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Next Generation Sequencing (NGS) size is estimated to be USD 6913.4 million in 2026 from USD 5146.8 million in 2020, with a change XX% between 2020 and 2021. The global Next Generation Sequencing (NGS) market size is expected to grow at a CAGR of 7.7% for the next five years.
Market segmentation
Next Generation Sequencing (NGS) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Targeted Sequencing
Whole Exome Sequencing
Whole Genome Sequencing
Market segment by Application, can be divided into
Academic & Government Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Hospitals & Clinics
Market segment by players, this report covers
Illumina
Thermo Fisher Scientific
Pacific Biosciences of California
Beijing Genomics Institute
Qiagen
Roche
Agilent Technologies
Perkinelmer
Genomatix
PierianDx
Eurofins Scientific
Gatc Biotech
Oxford Nanopore Technologies
Bio-Rad Laboratories
DNASTAR
Biomatters
Partek
New England Biolabs
Myriad Genetics
Macrogen
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Next Generation Sequencing (NGS) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Next Generation Sequencing (NGS), with revenue, gross margin and global market share of Next Generation Sequencing (NGS) from 2019 to 2021.
Chapter 3, the Next Generation Sequencing (NGS) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Next Generation Sequencing (NGS) market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Next Generation Sequencing (NGS) research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Next Generation Sequencing (NGS)
1.2 Classification of Next Generation Sequencing (NGS) by Type
1.2.1 Overview: Global Next Generation Sequencing (NGS) Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Next Generation Sequencing (NGS) Revenue Market Share by Type in 2020
1.2.3 Targeted Sequencing
1.2.4 Whole Exome Sequencing
1.2.5 Whole Genome Sequencing
1.3 Global Next Generation Sequencing (NGS) Market by Application
1.3.1 Overview: Global Next Generation Sequencing (NGS) Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Academic & Government Research Institutes
1.3.3 Pharmaceutical Companies
1.3.4 Biotechnology Companies
1.3.5 Hospitals & Clinics
1.4 Global Next Generation Sequencing (NGS) Market Size & Forecast
1.5 Global Next Generation Sequencing (NGS) Market Size and Forecast by Region
1.5.1 Global Next Generation Sequencing (NGS) Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Next Generation Sequencing (NGS) Market Size by Region, (2016-2021)
1.5.3 North America Next Generation Sequencing (NGS) Market Size and Prospect (2016-2026)
1.5.4 Europe Next Generation Sequencing (NGS) Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Next Generation Sequencing (NGS) Market Size and Prospect (2016-2026)
1.5.6 South America Next Generation Sequencing (NGS) Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Next Generation Sequencing (NGS) Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Next Generation Sequencing (NGS) Market Drivers
1.6.2 Next Generation Sequencing (NGS) Market Restraints
1.6.3 Next Generation Sequencing (NGS) Trends Analysis
2 Company Profiles
2.1 Illumina
2.1.1 Illumina Details
2.1.2 Illumina Major Business
2.1.3 Illumina Next Generation Sequencing (NGS) Product and Solutions
2.1.4 Illumina Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Illumina Recent Developments and Future Plans
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific Next Generation Sequencing (NGS) Product and Solutions
2.2.4 Thermo Fisher Scientific Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.3 Pacific Biosciences of California
2.3.1 Pacific Biosciences of California Details
2.3.2 Pacific Biosciences of California Major Business
2.3.3 Pacific Biosciences of California Next Generation Sequencing (NGS) Product and Solutions
2.3.4 Pacific Biosciences of California Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Pacific Biosciences of California Recent Developments and Future Plans
2.4 Beijing Genomics Institute
2.4.1 Beijing Genomics Institute Details
2.4.2 Beijing Genomics Institute Major Business
2.4.3 Beijing Genomics Institute Next Generation Sequencing (NGS) Product and Solutions
2.4.4 Beijing Genomics Institute Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Beijing Genomics Institute Recent Developments and Future Plans
2.5 Qiagen
2.5.1 Qiagen Details
2.5.2 Qiagen Major Business
2.5.3 Qiagen Next Generation Sequencing (NGS) Product and Solutions
2.5.4 Qiagen Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Qiagen Recent Developments and Future Plans
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business
2.6.3 Roche Next Generation Sequencing (NGS) Product and Solutions
2.6.4 Roche Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Roche Recent Developments and Future Plans
2.7 Agilent Technologies
2.7.1 Agilent Technologies Details
2.7.2 Agilent Technologies Major Business
2.7.3 Agilent Technologies Next Generation Sequencing (NGS) Product and Solutions
2.7.4 Agilent Technologies Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Agilent Technologies Recent Developments and Future Plans
2.8 Perkinelmer
2.8.1 Perkinelmer Details
2.8.2 Perkinelmer Major Business
2.8.3 Perkinelmer Next Generation Sequencing (NGS) Product and Solutions
2.8.4 Perkinelmer Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Perkinelmer Recent Developments and Future Plans
2.9 Genomatix
2.9.1 Genomatix Details
2.9.2 Genomatix Major Business
2.9.3 Genomatix Next Generation Sequencing (NGS) Product and Solutions
2.9.4 Genomatix Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Genomatix Recent Developments and Future Plans
2.10 PierianDx
2.10.1 PierianDx Details
2.10.2 PierianDx Major Business
2.10.3 PierianDx Next Generation Sequencing (NGS) Product and Solutions
2.10.4 PierianDx Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 PierianDx Recent Developments and Future Plans
2.11 Eurofins Scientific
2.11.1 Eurofins Scientific Details
2.11.2 Eurofins Scientific Major Business
2.11.3 Eurofins Scientific Next Generation Sequencing (NGS) Product and Solutions
2.11.4 Eurofins Scientific Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Eurofins Scientific Recent Developments and Future Plans
2.12 Gatc Biotech
2.12.1 Gatc Biotech Details
2.12.2 Gatc Biotech Major Business
2.12.3 Gatc Biotech Next Generation Sequencing (NGS) Product and Solutions
2.12.4 Gatc Biotech Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Gatc Biotech Recent Developments and Future Plans
2.13 Oxford Nanopore Technologies
2.13.1 Oxford Nanopore Technologies Details
2.13.2 Oxford Nanopore Technologies Major Business
2.13.3 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Product and Solutions
2.13.4 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Oxford Nanopore Technologies Recent Developments and Future Plans
2.14 Bio-Rad Laboratories
2.14.1 Bio-Rad Laboratories Details
2.14.2 Bio-Rad Laboratories Major Business
2.14.3 Bio-Rad Laboratories Next Generation Sequencing (NGS) Product and Solutions
2.14.4 Bio-Rad Laboratories Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.15 DNASTAR
2.15.1 DNASTAR Details
2.15.2 DNASTAR Major Business
2.15.3 DNASTAR Next Generation Sequencing (NGS) Product and Solutions
2.15.4 DNASTAR Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 DNASTAR Recent Developments and Future Plans
2.16 Biomatters
2.16.1 Biomatters Details
2.16.2 Biomatters Major Business
2.16.3 Biomatters Next Generation Sequencing (NGS) Product and Solutions
2.16.4 Biomatters Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Biomatters Recent Developments and Future Plans
2.17 Partek
2.17.1 Partek Details
2.17.2 Partek Major Business
2.17.3 Partek Next Generation Sequencing (NGS) Product and Solutions
2.17.4 Partek Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Partek Recent Developments and Future Plans
2.18 New England Biolabs
2.18.1 New England Biolabs Details
2.18.2 New England Biolabs Major Business
2.18.3 New England Biolabs Next Generation Sequencing (NGS) Product and Solutions
2.18.4 New England Biolabs Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 New England Biolabs Recent Developments and Future Plans
2.19 Myriad Genetics
2.19.1 Myriad Genetics Details
2.19.2 Myriad Genetics Major Business
2.19.3 Myriad Genetics Next Generation Sequencing (NGS) Product and Solutions
2.19.4 Myriad Genetics Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Myriad Genetics Recent Developments and Future Plans
2.20 Macrogen
2.20.1 Macrogen Details
2.20.2 Macrogen Major Business
2.20.3 Macrogen Next Generation Sequencing (NGS) Product and Solutions
2.20.4 Macrogen Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 Macrogen Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Next Generation Sequencing (NGS) Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Next Generation Sequencing (NGS) Players Market Share
3.2.2 Top 10 Next Generation Sequencing (NGS) Players Market Share
3.2.3 Market Competition Trend
3.3 Next Generation Sequencing (NGS) Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Next Generation Sequencing (NGS) Revenue and Market Share by Type (2016-2021)
4.2 Global Next Generation Sequencing (NGS) Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Next Generation Sequencing (NGS) Revenue Market Share by Application (2016-2021)
5.2 Next Generation Sequencing (NGS) Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Next Generation Sequencing (NGS) Revenue by Type (2016-2026)
6.2 North America Next Generation Sequencing (NGS) Revenue by Application (2016-2026)
6.3 North America Next Generation Sequencing (NGS) Market Size by Country
6.3.1 North America Next Generation Sequencing (NGS) Revenue by Country (2016-2026)
6.3.2 United States Next Generation Sequencing (NGS) Market Size and Forecast (2016-2026)
6.3.3 Canada Next Generation Sequencing (NGS) Market Size and Forecast (2016-2026)
6.3.4 Mexico Next Generation Sequencing (NGS) Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Next Generation Sequencing (NGS) Revenue by Type (2016-2026)
7.2 Europe Next Generation Sequencing (NGS) Revenue by Application (2016-2026)
7.3 Europe Next Generation Sequencing (NGS) Market Size by Country
7.3.1 Europe Next Generation Sequencing (NGS) Revenue by Country (2016-2026)
7.3.2 Germany Next Generation Sequencing (NGS) Market Size and Forecast (2016-2026)
7.3.3 France Next Generation Sequencing (NGS) Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Next Generation Sequencing (NGS) Market Size and Forecast (2016-2026)
7.3.5 Russia Next Generation Sequencing (NGS) Market Size and Forecast (2016-2026)
7.3.6 Italy Next Generation Sequencing (NGS) Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Next Generation Sequencing (NGS) Revenue by Type (2016-2026)
8.2 Asia-Pacific Next Generation Sequencing (NGS) Revenue by Application (2016-2026)
8.3 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Region
8.3.1 Asia-Pacific Next Generation Sequencing (NGS) Revenue by Region (2016-2026)
8.3.2 China Next Generation Sequencing (NGS) Market Size and Forecast (2016-2026)
8.3.3 Japan Next Generation Sequencing (NGS) Market Size and Forecast (2016-2026)
8.3.4 South Korea Next Generation Sequencing (NGS) Market Size and Forecast (2016-2026)
8.3.5 India Next Generation Sequencing (NGS) Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Next Generation Sequencing (NGS) Market Size and Forecast (2016-2026)
8.3.7 Australia Next Generation Sequencing (NGS) Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Next Generation Sequencing (NGS) Revenue by Type (2016-2026)
9.2 South America Next Generation Sequencing (NGS) Revenue by Application (2016-2026)
9.3 South America Next Generation Sequencing (NGS) Market Size by Country
9.3.1 South America Next Generation Sequencing (NGS) Revenue by Country (2016-2026)
9.3.2 Brazil Next Generation Sequencing (NGS) Market Size and Forecast (2016-2026)
9.3.3 Argentina Next Generation Sequencing (NGS) Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Next Generation Sequencing (NGS) Revenue by Type (2016-2026)
10.2 Middle East & Africa Next Generation Sequencing (NGS) Revenue by Application (2016-2026)
10.3 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Country
10.3.1 Middle East & Africa Next Generation Sequencing (NGS) Revenue by Country (2016-2026)
10.3.2 Turkey Next Generation Sequencing (NGS) Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Next Generation Sequencing (NGS) Market Size and Forecast (2016-2026)
10.3.4 UAE Next Generation Sequencing (NGS) Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Next Generation Sequencing (NGS) Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Next Generation Sequencing (NGS) Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Next Generation Sequencing (NGS) Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Next Generation Sequencing (NGS) Revenue (USD Million) by Region (2016-2021)
Table 5. Global Next Generation Sequencing (NGS) Revenue Market Share by Region (2021-2026)
Table 6. Illumina Corporate Information, Head Office, and Major Competitors
Table 7. Illumina Major Business
Table 8. Illumina Next Generation Sequencing (NGS) Product and Solutions
Table 9. Illumina Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific Major Business
Table 12. Thermo Fisher Scientific Next Generation Sequencing (NGS) Product and Solutions
Table 13. Thermo Fisher Scientific Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Pacific Biosciences of California Corporate Information, Head Office, and Major Competitors
Table 15. Pacific Biosciences of California Major Business
Table 16. Pacific Biosciences of California Next Generation Sequencing (NGS) Product and Solutions
Table 17. Pacific Biosciences of California Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Beijing Genomics Institute Corporate Information, Head Office, and Major Competitors
Table 19. Beijing Genomics Institute Major Business
Table 20. Beijing Genomics Institute Next Generation Sequencing (NGS) Product and Solutions
Table 21. Beijing Genomics Institute Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Qiagen Corporate Information, Head Office, and Major Competitors
Table 23. Qiagen Major Business
Table 24. Qiagen Next Generation Sequencing (NGS) Product and Solutions
Table 25. Qiagen Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Roche Corporate Information, Head Office, and Major Competitors
Table 27. Roche Major Business
Table 28. Roche Next Generation Sequencing (NGS) Product and Solutions
Table 29. Roche Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Agilent Technologies Corporate Information, Head Office, and Major Competitors
Table 31. Agilent Technologies Major Business
Table 32. Agilent Technologies Next Generation Sequencing (NGS) Product and Solutions
Table 33. Agilent Technologies Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Perkinelmer Corporate Information, Head Office, and Major Competitors
Table 35. Perkinelmer Major Business
Table 36. Perkinelmer Next Generation Sequencing (NGS) Product and Solutions
Table 37. Perkinelmer Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Genomatix Corporate Information, Head Office, and Major Competitors
Table 39. Genomatix Major Business
Table 40. Genomatix Next Generation Sequencing (NGS) Product and Solutions
Table 41. Genomatix Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. PierianDx Corporate Information, Head Office, and Major Competitors
Table 43. PierianDx Major Business
Table 44. PierianDx Next Generation Sequencing (NGS) Product and Solutions
Table 45. PierianDx Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Eurofins Scientific Corporate Information, Head Office, and Major Competitors
Table 47. Eurofins Scientific Major Business
Table 48. Eurofins Scientific Next Generation Sequencing (NGS) Product and Solutions
Table 49. Eurofins Scientific Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Gatc Biotech Corporate Information, Head Office, and Major Competitors
Table 51. Gatc Biotech Major Business
Table 52. Gatc Biotech Next Generation Sequencing (NGS) Product and Solutions
Table 53. Gatc Biotech Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Oxford Nanopore Technologies Corporate Information, Head Office, and Major Competitors
Table 55. Oxford Nanopore Technologies Major Business
Table 56. Oxford Nanopore Technologies Next Generation Sequencing (NGS) Product and Solutions
Table 57. Oxford Nanopore Technologies Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 59. Bio-Rad Laboratories Major Business
Table 60. Bio-Rad Laboratories Next Generation Sequencing (NGS) Product and Solutions
Table 61. Bio-Rad Laboratories Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. DNASTAR Corporate Information, Head Office, and Major Competitors
Table 63. DNASTAR Major Business
Table 64. DNASTAR Next Generation Sequencing (NGS) Product and Solutions
Table 65. DNASTAR Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Biomatters Corporate Information, Head Office, and Major Competitors
Table 67. Biomatters Major Business
Table 68. Biomatters Next Generation Sequencing (NGS) Product and Solutions
Table 69. Biomatters Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Partek Corporate Information, Head Office, and Major Competitors
Table 71. Partek Major Business
Table 72. Partek Next Generation Sequencing (NGS) Product and Solutions
Table 73. Partek Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. New England Biolabs Corporate Information, Head Office, and Major Competitors
Table 75. New England Biolabs Major Business
Table 76. New England Biolabs Next Generation Sequencing (NGS) Product and Solutions
Table 77. New England Biolabs Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Myriad Genetics Corporate Information, Head Office, and Major Competitors
Table 79. Myriad Genetics Major Business
Table 80. Myriad Genetics Next Generation Sequencing (NGS) Product and Solutions
Table 81. Myriad Genetics Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. Macrogen Corporate Information, Head Office, and Major Competitors
Table 83. Macrogen Major Business
Table 84. Macrogen Next Generation Sequencing (NGS) Product and Solutions
Table 85. Macrogen Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 86. Global Next Generation Sequencing (NGS) Revenue (USD Million) by Players (2019-2021)
Table 87. Global Next Generation Sequencing (NGS) Revenue Share by Players (2019-2021)
Table 88. Breakdown of Next Generation Sequencing (NGS) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 89. Next Generation Sequencing (NGS) Players Head Office, Products and Services Provided
Table 90. Next Generation Sequencing (NGS) Mergers & Acquisitions in the Past Five Years
Table 91. Next Generation Sequencing (NGS) New Entrants and Expansion Plans
Table 92. Global Next Generation Sequencing (NGS) Revenue (USD Million) by Type (2016-2021)
Table 93. Global Next Generation Sequencing (NGS) Revenue Share by Type (2016-2021)
Table 94. Global Next Generation Sequencing (NGS) Revenue Forecast by Type (2021-2026)
Table 95. Global Next Generation Sequencing (NGS) Revenue by Application (2016-2021)
Table 96. Global Next Generation Sequencing (NGS) Revenue Forecast by Application (2021-2026)
Table 97. North America Next Generation Sequencing (NGS) Revenue by Type (2016-2021) & (USD Million)
Table 98. North America Next Generation Sequencing (NGS) Revenue by Type (2021-2026) & (USD Million)
Table 99. North America Next Generation Sequencing (NGS) Revenue by Application (2016-2021) & (USD Million)
Table 100. North America Next Generation Sequencing (NGS) Revenue by Application (2021-2026) & (USD Million)
Table 101. North America Next Generation Sequencing (NGS) Revenue by Country (2016-2021) & (USD Million)
Table 102. North America Next Generation Sequencing (NGS) Revenue by Country (2021-2026) & (USD Million)
Table 103. Europe Next Generation Sequencing (NGS) Revenue by Type (2016-2021) & (USD Million)
Table 104. Europe Next Generation Sequencing (NGS) Revenue by Type (2021-2026) & (USD Million)
Table 105. Europe Next Generation Sequencing (NGS) Revenue by Application (2016-2021) & (USD Million)
Table 106. Europe Next Generation Sequencing (NGS) Revenue by Application (2021-2026) & (USD Million)
Table 107. Europe Next Generation Sequencing (NGS) Revenue by Country (2016-2021) & (USD Million)
Table 108. Europe Next Generation Sequencing (NGS) Revenue by Country (2021-2026) & (USD Million)
Table 109. Asia-Pacific Next Generation Sequencing (NGS) Revenue by Type (2016-2021) & (USD Million)
Table 110. Asia-Pacific Next Generation Sequencing (NGS) Revenue by Type (2021-2026) & (USD Million)
Table 111. Asia-Pacific Next Generation Sequencing (NGS) Revenue by Application (2016-2021) & (USD Million)
Table 112. Asia-Pacific Next Generation Sequencing (NGS) Revenue by Application (2021-2026) & (USD Million)
Table 113. Asia-Pacific Next Generation Sequencing (NGS) Revenue by Region (2016-2021) & (USD Million)
Table 114. Asia-Pacific Next Generation Sequencing (NGS) Revenue by Region (2021-2026) & (USD Million)
Table 115. South America Next Generation Sequencing (NGS) Revenue by Type (2016-2021) & (USD Million)
Table 116. South America Next Generation Sequencing (NGS) Revenue by Type (2021-2026) & (USD Million)
Table 117. South America Next Generation Sequencing (NGS) Revenue by Application (2016-2021) & (USD Million)
Table 118. South America Next Generation Sequencing (NGS) Revenue by Application (2021-2026) & (USD Million)
Table 119. South America Next Generation Sequencing (NGS) Revenue by Country (2016-2021) & (USD Million)
Table 120. South America Next Generation Sequencing (NGS) Revenue by Country (2021-2026) & (USD Million)
Table 121. Middle East & Africa Next Generation Sequencing (NGS) Revenue by Type (2016-2021) & (USD Million)
Table 122. Middle East & Africa Next Generation Sequencing (NGS) Revenue by Type (2021-2026) & (USD Million)
Table 123. Middle East & Africa Next Generation Sequencing (NGS) Revenue by Application (2016-2021) & (USD Million)
Table 124. Middle East & Africa Next Generation Sequencing (NGS) Revenue by Application (2021-2026) & (USD Million)
Table 125. Middle East & Africa Next Generation Sequencing (NGS) Revenue by Country (2016-2021) & (USD Million)
Table 126. Middle East & Africa Next Generation Sequencing (NGS) Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Next Generation Sequencing (NGS) Picture
Figure 2. Global Next Generation Sequencing (NGS) Revenue Market Share by Type in 2020
Figure 3. Targeted Sequencing
Figure 4. Whole Exome Sequencing
Figure 5. Whole Genome Sequencing
Figure 6. Next Generation Sequencing (NGS) Revenue Market Share by Application in 2020
Figure 7. Academic & Government Research Institutes Picture
Figure 8. Pharmaceutical Companies Picture
Figure 9. Biotechnology Companies Picture
Figure 10. Hospitals & Clinics Picture
Figure 11. Global Next Generation Sequencing (NGS) Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Next Generation Sequencing (NGS) Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Next Generation Sequencing (NGS) Revenue Market Share by Region (2016-2026)
Figure 14. Global Next Generation Sequencing (NGS) Revenue Market Share by Region in 2020
Figure 15. North America Next Generation Sequencing (NGS) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Next Generation Sequencing (NGS) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Next Generation Sequencing (NGS) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Next Generation Sequencing (NGS) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Next Generation Sequencing (NGS) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Next Generation Sequencing (NGS) Market Drivers
Figure 21. Next Generation Sequencing (NGS) Market Restraints
Figure 22. Next Generation Sequencing (NGS) Market Trends
Figure 23. Illumina Recent Developments and Future Plans
Figure 24. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 25. Pacific Biosciences of California Recent Developments and Future Plans
Figure 26. Beijing Genomics Institute Recent Developments and Future Plans
Figure 27. Qiagen Recent Developments and Future Plans
Figure 28. Roche Recent Developments and Future Plans
Figure 29. Agilent Technologies Recent Developments and Future Plans
Figure 30. Perkinelmer Recent Developments and Future Plans
Figure 31. Genomatix Recent Developments and Future Plans
Figure 32. PierianDx Recent Developments and Future Plans
Figure 33. Eurofins Scientific Recent Developments and Future Plans
Figure 34. Gatc Biotech Recent Developments and Future Plans
Figure 35. Oxford Nanopore Technologies Recent Developments and Future Plans
Figure 36. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 37. DNASTAR Recent Developments and Future Plans
Figure 38. Biomatters Recent Developments and Future Plans
Figure 39. Partek Recent Developments and Future Plans
Figure 40. New England Biolabs Recent Developments and Future Plans
Figure 41. Myriad Genetics Recent Developments and Future Plans
Figure 42. Macrogen Recent Developments and Future Plans
Figure 43. Global Next Generation Sequencing (NGS) Revenue Share by Players in 2020
Figure 44. Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 45. Global Top 3 Players Next Generation Sequencing (NGS) Revenue Market Share in 2020
Figure 46. Global Top 10 Players Next Generation Sequencing (NGS) Revenue Market Share in 2020
Figure 47. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 48. Global Next Generation Sequencing (NGS) Revenue Share by Type in 2020
Figure 49. Global Next Generation Sequencing (NGS) Market Share Forecast by Type (2021-2026)
Figure 50. Global Next Generation Sequencing (NGS) Revenue Share by Application in 2020
Figure 51. Global Next Generation Sequencing (NGS) Market Share Forecast by Application (2021-2026)
Figure 52. North America Next Generation Sequencing (NGS) Sales Market Share by Type (2016-2026)
Figure 53. North America Next Generation Sequencing (NGS) Sales Market Share by Application (2016-2026)
Figure 54. North America Next Generation Sequencing (NGS) Revenue Market Share by Country (2016-2026)
Figure 55. United States Next Generation Sequencing (NGS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Canada Next Generation Sequencing (NGS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Mexico Next Generation Sequencing (NGS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Europe Next Generation Sequencing (NGS) Sales Market Share by Type (2016-2026)
Figure 59. Europe Next Generation Sequencing (NGS) Sales Market Share by Application (2016-2026)
Figure 60. Europe Next Generation Sequencing (NGS) Revenue Market Share by Country (2016-2026)
Figure 61. Germany Next Generation Sequencing (NGS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. France Next Generation Sequencing (NGS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. United Kingdom Next Generation Sequencing (NGS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Russia Next Generation Sequencing (NGS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Italy Next Generation Sequencing (NGS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Asia-Pacific Next Generation Sequencing (NGS) Sales Market Share by Type (2016-2026)
Figure 67. Asia-Pacific Next Generation Sequencing (NGS) Sales Market Share by Application (2016-2026)
Figure 68. Asia-Pacific Next Generation Sequencing (NGS) Revenue Market Share by Region (2016-2026)
Figure 69. China Next Generation Sequencing (NGS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Japan Next Generation Sequencing (NGS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. South Korea Next Generation Sequencing (NGS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. India Next Generation Sequencing (NGS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Southeast Asia Next Generation Sequencing (NGS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Australia Next Generation Sequencing (NGS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South America Next Generation Sequencing (NGS) Sales Market Share by Type (2016-2026)
Figure 76. South America Next Generation Sequencing (NGS) Sales Market Share by Application (2016-2026)
Figure 77. South America Next Generation Sequencing (NGS) Revenue Market Share by Country (2016-2026)
Figure 78. Brazil Next Generation Sequencing (NGS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Argentina Next Generation Sequencing (NGS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Middle East and Africa Next Generation Sequencing (NGS) Sales Market Share by Type (2016-2026)
Figure 81. Middle East and Africa Next Generation Sequencing (NGS) Sales Market Share by Application (2016-2026)
Figure 82. Middle East and Africa Next Generation Sequencing (NGS) Revenue Market Share by Country (2016-2026)
Figure 83. Turkey Next Generation Sequencing (NGS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Saudi Arabia Next Generation Sequencing (NGS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. UAE Next Generation Sequencing (NGS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 86. Methodology
Figure 87. Research Process and Data Source
Buy
